Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ASEBOGENIN
ID: ALA253257
Max Phase: Preclinical
Molecular Formula: C16H16O5
Molecular Weight: 288.30
Molecule Type: Small molecule
Associated Items:
ID: ALA253257
Max Phase: Preclinical
Molecular Formula: C16H16O5
Molecular Weight: 288.30
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Asebogenin
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(O)c(C(=O)CCc2ccc(O)cc2)c(O)c1
Standard InChI: InChI=1S/C16H16O5/c1-21-12-8-14(19)16(15(20)9-12)13(18)7-4-10-2-5-11(17)6-3-10/h2-3,5-6,8-9,17,19-20H,4,7H2,1H3
Standard InChI Key: UPXIBKPHJYQSGP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 288.30 | Molecular Weight (Monoisotopic): 288.0998 | AlogP: 2.63 | #Rotatable Bonds: 5 |
Polar Surface Area: 86.99 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.79 | CX Basic pKa: | CX LogP: 4.04 | CX LogD: 4.02 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: 0.73 |
1. Nowakowska Z.. (2007) A review of anti-infective and anti-inflammatory chalcones., 42 (2): [PMID:17112640] [10.1016/j.ejmech.2006.09.019] |
2. Orjala J, Wright AD, Behrends H, Folkers G, Sticher O, Rüegger H, Rali T.. (1994) Cytotoxic and antibacterial dihydrochalcones from Piper aduncum., 57 (1): [PMID:8158163] [10.1021/np50103a003] |
3. Mancini SD, Edwards JM.. (1979) Cytotoxic principles from the sap of Kalmia latifolia., 42 (5): [PMID:521818] [10.1021/np50005a008] |
4. Li XC, Joshi AS, ElSohly HN, Khan SI, Jacob MR, Zhang Z, Khan IA, Ferreira D, Walker LA, Broedel SE, Raulli RE, Cihlar RL.. (2002) Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies., 65 (12): [PMID:12502337] [10.1021/np020289t] |
5. Yao GM, Ding Y, Zuo JP, Wang HB, Wang YB, Ding BY, Chiu P, Qin GW.. (2005) Dihydrochalcones from the leaves of Pieris japonica., 68 (3): [PMID:15787442] [10.1021/np049698a] |
Source(1):